Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01240122 · ClinicalTrials.gov registry record · NA
Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions
A NA study, sponsored by Abbott Medical Optics.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01240122 is a NA study that has completed, run by Abbott Medical Optics. The registered enrollment target is 30 participants.
The verdict
NCT01240122, a NA study, has completed, sponsored by Abbott Medical Optics.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
An investigational multi-purpose solution (MPS)was clinically evaluated against Biotrue MPS at specific time points over the course of four days. The study was conducted with PureVision lenses.
Interventions
- DEVICE Investigational MPS
- DEVICE Biotrue MPS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-08-31 |
| Est. Completion | 2010-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01240122
The ClinicalTrials.gov registry entry for NCT01240122 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Optics, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Investigational MPS is the first listed.
NCT01240122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01240122 about?
NCT01240122 is a clinical study titled "Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions". An investigational multi-purpose solution (MPS)was clinically evaluated against Biotrue MPS at specific time points over the course of four days. The study was conducted with PureVision lenses.
What is the current status of trial NCT01240122?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2010-08-31. Estimated completion is 2010-11-30.
What interventions are being tested in trial NCT01240122?
The interventions under investigation include: Investigational MPS (DEVICE), Biotrue MPS (DEVICE).
Who is sponsoring clinical trial NCT01240122?
This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.